Highly selective fluorescent analogue of the potent δ-opioid receptor antagonist Dmt-Tic

Journal of Medicinal Chemistry

Volumn 47, Issue 26, 2004, Pages 6541-6546

  Balboni, Gianfranco ^a   Salvadori, Severe ^b   Piaz, Alessandro Dal ^b   Bortolotti, Fabrizio ^b   Argazzi, Roberto ^b   Negri, Lucia ^c   Lattanzi, Roberta ^c   Bryant, Sharon D ^d   Jinsmaa, Yunden ^d   Lazarus, Lawrence H ^d  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',6' DIMETHYLTYROSINE 1,2,3,4 TETRAHYDROISOQUINOLIN 3 CARBOXYLIC ACID; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR ANTAGONIST; FLUORESCEIN; FLUORESCENT DYE; NALTRINDOLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; COMPARATIVE STUDY; DRUG ACTIVITY; DRUG RECEPTOR BINDING; NONHUMAN; PEPTIDE SYNTHESIS; RAT; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; BRAIN; CELL LINE; DIPEPTIDES; ELECTRIC STIMULATION; FLUORESCENT DYES; GUINEA PIGS; ILEUM; MALE; MICE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; RADIOLIGAND ASSAY; RATS; RECEPTORS, OPIOID, DELTA; SYNAPTOSOMES; TETRAHYDROISOQUINOLINES; VAS DEFERENS;

EID: 10644279908     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm040128h     Document Type: Article

References (29)

1. 2, negative log of the molar concentration required to double the agonist concentration to achieve the original response; TFA, trifluoroacetic acid; Tic, 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid; TIP(P), H-Tyr-Tic-Phe-(Phe)-OH; TLC, thin-layer chromatography; WSC, 1-ethyl-3-(3′-dimethylaminopropyl)carbodiimide·HCl.
2. Aldrich, J. V. Analgesics. In Burger's Medicinal Chemistry and Drug Discovery, 5th ed.; Wolff, M. E., Ed.; John Wiley & Sons: New York, 1996; pp 321-441.
3. Carraway, K. L.; Cerione, R. A. Fluorescent-labelled growth factor molecules serve as probes for receptor binding and endocytosis. Biochemistry 1993, 32, 12039-12045.
4. Fay, S. P.; Posner, R. G.; Swann, W. N.; Sklar, L. A. Real-time analysis of the assembly of ligand, receptor, and G-protein by quantitative fluorescence flow cytometry. Biochemistry 1991, 30, 5066-5075.
5. Tota, M. R.; Daniel, S.; Sirotina, A.; Mazina, K. E.; Fong, T. M.; Longmore, J.; Strader, C. D. Characterization of a fluorescent Substance P analogue. Biochemistry 1994, 33, 13079-13086.
6. Carraway, K. L.; Koland, J. G.; Cerione, R. A. Location of the epidermal growth factor binding site on the EGF receptor. A resonance energy transfer study. Biochemistry 1990, 29, 8741-8747.
7. Hazzum, E.; Chang, K. J.; Shecter, Y.; Wilkinson, S.; Cautrecasas, P. Fluorescent and photoaffinity enkephalin derivatives: preparation and interaction with opiate receptors. Biochem. Biophys. Res. Commun. 1979, 88, 841-846.
8. Mihara, H.; Lee, S.; Shimohigashi, Y.; Aoyagi, H.; Kato, T.; Izumiya, N.; Costa, T. μ and δ Opioid receptor probes: fluorescent enkephalins with high receptor affinity and specificity. FEBS Lett. 1985, 193, 35-38.
9. 1]DALDA. Peptides 2003, 24, 1195-1200.
10. 1]DALDA: in vitro activity profiles and fluorescence parameters. Acta Biochim. Pol. 2004, 51, 107-113.
11. Goldstein, A.; Nestor, J. J.; Naidu, A.; Newman, S. R. "DAKLI": A multipurpose ligand with high affinity and selectivity for dynorphin (κ opioid) binding sites. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 7375-7379.
12. Kshirsagar, T.; Nakano, A. H:, Law, P.-Y.; Elde, R.; Portoghese, P. S. NTI4F: a non-peptide fluorescent probe selective for functional delta opioid receptors. Neurosci. Lett. 1998, 249, 83-86.
13. Kumar, V.; Murray, T. F.; Aldrich, J. V. Extended TIP(P) Analogues as precursors for labeled δ-opioid receptor ligands. J. Med. Chem. 2000, 43, 5050-5054.
14. Chang, A.-C.; Chao, C. C.; Takemori, A. E.; Gekker, G.; Hu, S.; Peterson, P. K.; Portoghese, P. S. Arylacetamide-derived fluorescent probes: synthesis, biological evaluation, and direct fluorescent labeling of δ opioid receptors in mouse microglial cells. J. Med. Chem. 1996, 39, 1729-1735.
15. Salvadori, S.; Attila, M.; Balboni, G.; Bianchi, C.; Bryant, S. D.; Crescenzi, O.; Guerrini, R.; Picone, D.; Tancredi, T.; Temussi, P. A.; Lazarus, L. H. δ Opioid mimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides. Mol. Med. 1995, 1, 678-689.
16. Temussi, P. A.; Salvadori, S.; Amodeo, P.; Bianchi, C.; Guerrini, R.; Tomatis, R.; Lazarus, L. H.; Tancredi, T. Selective opioid dipeptides. Biochem. Biophys. Res. Commun. 1994, 198, 933-939.
17. Schiller, P. W.; Nguyen, T. M.-D.; Weltrowska, G.; Wilkes, B. C.; Marsden, J.; Lemieux, C.; Chung, N. N. Differential stereochemical requirements of δ vs δ opioid receptors for ligand binding and signal transduction: development of a class of potent and highly δ-selective peptide antagonists. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 11871-11875.
18. Balboni, G.; Salvadori, S.; Guerrini, R.; Negri, L.; Giannini, E.; Jinsmaa, Y.; Bryant, S. D.; Lazarus, L. H. Potent δ-opioid receptor agonists containing the Dmt-Tic pharmacophore. J. Med. Chem. 2002, 45, 5556-5563.
19. Balboni, G.; Salvadori, S.; Guerrini, R.; Negri, L.; Giannini, E.; Bryant, S. D.; Jinsmaa, Y.; Lazarus, L. H. Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on δ-opioid receptor selectivity and δ-opioid receptor antagonism. J. Med. Chem. 2004, 47, 4066-4071.
20. Lazarus, L. H.; Salvadori, S.; Santagada, V.; Tomatis, R.; Wilson, W. E. Function of negative charge in the "address domain" of deltorphins. J. Med. Chem. 1991, 34, 1350-1359.
21. Salvadori, S.; Guerrini, R.; Balboni, G.; Bryant, S. D.; Cooper, P. S.; Lazarus, L. H. Further studies on the Dmt-Tic pharmacophore: hydrophobic substituents at the C-terminus endows δ antagonists to manifest δ agonism or μ antagonism. J. Med. Chem. 1999, 42, 5010-5019.
22. Balboni, G.; Salvadori, S.; Guerrini, R.; Negri, L.; Giannini, E.; Bryant, S. D.; Jinsmaa, Y.; Lazarus, L. H. Synthesis and opioid activity of N,N-dimethyl-Dmt-Tic-NH-CH(R)-R′ analogues: acquisition of potent δ antagonism. Bioorg. Med. Chem. 2003, 11, 5435-5441.
23. Lazarus, L. H.; Wilson, W. E.; De Castiglione, R.; Guglietta, A. Dermorphin gene sequence peptide with high affinity and selectivity for δ-opioid receptors. J. Biol. Chem. 1989, 264, 3047-3050.
24. 50) of an enzymatic reaction. Biochem. Pharmacol. 1973, 22, 3099-3108.
25. Melchiorri, P.; Negri, L.; Falconieri-Erspamer, G.; Severini, C.; Corsi, R.; Soaje, M.; Erspamer, V.; Barra, D. Structure-activity relationships of the δ-opioid-selective agonists, deltorphins. Eur. J. Pharmacol. 1991, 195, 201-207.
26. Tallarida, R. J.; Murray, R. B. Manual of Pharmacological Calculation, 2nd ed.; Springer-Verlag: New York, 1986.
27. Meech, S. R.; Phillips, D. J. Photochem. 1983, 23, 193.
28. Korlipara, V.; Ells, J.; Wang, J.; Tam, S.; Elde, R.; Portoghese, P. Fluorescent N-benzylnaltrindole analogues as potential delta opioid receptor selective probes. Eur. J. Med. Chem. 1997, 32, 171-174.
29. Arttamangkul, S.; Alvarez-Maubecin, V.; Thomas, G.; Williams, J. T.; Grandy, D. K. Binding and internalization of fluorescent opioid peptide conjugates in living cells. Mol. Pharmacol. 2000, 58, 1570-1580.